Individual clinical trials provide useful information, but meta-analyses offer the strongest evidence because they analyze results across many studies.
Multiple meta-analyses have investigated the effectiveness of neurofeedback for ADHD.
One systematic review analyzing numerous randomized controlled trials concluded that neurofeedback significantly improved attention and reduced hyperactivity compared with inactive control conditions.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9762555/
Another review published in Scientific Reports found improvements in executive functioning, working memory, and inhibitory control following neurofeedback training.
https://www.nature.com/articles/s41598-025-94242-4
However, not all meta-analyses report identical results. Some researchers argue that study designs, training protocols, and outcome measures vary significantly across trials.
A review in Translational Psychiatry highlights that methodological differences can influence outcomes but still acknowledges growing evidence supporting neurofeedback’s therapeutic potential.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6388544/
Overall, the consensus in the scientific literature is that neurofeedback is a promising non-pharmacological intervention for ADHD.
